Zachariah Serber, Chief Science Officer at Zymergen Inc. (ZY), sold 5,435 shares at $4.33 ($24K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Scheduled sale ($24k) by Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZY | SELL | 2022-08-04 | $8K | — | Filing → |
| ZY | SELL | 2022-07-07 | $4K | — | Filing → |
| ZY | SELL | 2022-06-06 | $5K | — | Filing → |